Business
Ventas, Inc.: We hold a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom.
Revenue increased 18.5% to $5.83B, while Net income increased 196.0% to $261.5M.
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $5.83BOK
- Profitability — Net income $261.5MOK
- Cash generation — Free cash flow ($1.28B)Note
- Accounting — No applicable forensic screenNote
- Insiders — 0 buys; 25 sells in 365 daysNote
- Capital — dividends paid were $860.1MNote
Where the revenue comes from
Fiscal 2025, as Ventas, Inc. reports it. History and quarterly detail are in the app.
- SHOP$4.3B
- Outpatient medical and research portfolio (OM&R)$897.9M
- NNN$601.6M
Leadership changes
From Ventas, Inc.'s own filings, the day they're filed.
- Roxanne Martino · CEO · departure
Latest filings
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-06-15
- 8-K · Company announcement2026-05-15
- 10-Q · Quarterly report2026-04-28
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Ventas, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.